Compassionate useNeuropeptide
Compound 62135
Formula Pending
Molecular Mass
N/A
CAS Registry
AUTO-062135
Risk Class
HIGH
Last Audit
Jan 22, 2109
Research Abstract
Neuropeptide candidate engineered for metabolic regulation initiatives with automated dossier coverage.
Compound 62135 is a neuropeptide asset inside neuropeptide innovation track initiatives, optimized for metabolic regulation and cardiometabolic recovery.
The dossier currently sits in compassionate use with a high risk rating, meaning it is restricted to black-box teams with hardened compliance.
Supply records cite CAS AUTO-062135 with updates logged 2109-01-22.
Acquisition Protocol
Authorized research personnel may request deployment of this compound for laboratory analysis.
Primary Vectors
Metabolic regulationCardiometabolic recovery
Nomenclature
CX-62135Neuropeptide Program 62135
Reference Material
- [1] Anubis Compound Registry • CAS AUTO-062135
- [2] Operations Pulse • Neuropeptide innovation track
- [3] Risk Governance Ledger • HIGH clearance for COMPOUND-62135